Therefore, CpdA ameliorated ethanol-induced hepatic steatosis (indicated by Oil red O staining) and improved the ethanol-induced increase in serum triglyceride, AST, and ALT levels, whereas AH7614 reversed these effects. The gene discussed is GPT; the disease is fatty liver disease.